Author:
Mahmoud Ramez H.,Biguetti Claudia C.,Simionato Gustavo B.,Custódio Isabela C.,Silva Raquel B. P.,Duarte Marco A. H.,Faverani Leonardo P.,Ervolino Edilson,Fakhouri Walid D.,Matsumoto Mariza A.
Abstract
AbstractThis study investigated the role 5-lypoxigenase (5-LO) on alveolar socket healing in aged female mice treated with zoledronic acid (ZL). Forty 129/Sv female mice (64–68 weeks old), 20 wild type (WT) and 20 5-LO knockout (5LOKO) were equally distributed according to ZL treatment: WT Control, WT ZL, 5LOKO Control, and 5LOKO ZL. ZL groups were treated with an intraperitoneal injection of 250 µg/Kg of ZL, while controls were treated with saline. Treatments were administered once a week, starting four weeks before surgery for tooth extraction and until 7 and 21 days post-surgery. Mice were euthanized for a comprehensive microscopic analysis (microCT, histomorphometry and immunohistochemistry). WT ZL mice presented intense inflammatory infiltrate (7 days), delayed bone formation (21 days), reduced collagenous matrix quality, and a deficiency in Runx-2 + , TRAP + , and macrophages as compared to controls. 5LOKO ZL animals presented decreased number of Runx-2 + cells in comparison to 5LOKO Control at 7 days, but no major changes in bone healing as compared to WT or 5LOKO mice at 21 days. The knockout of 5LO favored intramembranous bone healing in aged female mice, with a direct impact on inflammatory response and bone metabolism on the development of ONJ-like lesions.
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Chapurlat, R. D. et al. Longitudinal study of bone loss in pre- and perimenopausal women: Evidence for bone loss in perimenopausal women. Osteoporos. Int. 11, 493–498 (2000).
2. Boros, K. & Freemont, T. Physiology of ageing of the musculoskeletal system. Best practice and research: Clinical rheumatology. Bailliere Tindall Ltd. 31, 203–217 (2017).
3. Bitto, A. et al. Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: A comparative study with alendronate. Br. J. Pharmacol. 156, 1287–1295 (2009).
4. Eriksen, E. F., Díez-Pérez, A. & Boonen, S. Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review. Bone 58, 126–135 (2014).
5. Mortensen, M., Lawson, W. & Montazem, A. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review. Laryngoscope. 117, 30–34 (2007).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献